Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
QSX AB
AB
Active
Org 5594759796
Stenmåravägen 1, 194 60
Upplands Väsby
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2024
1 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
QSX AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2024
1M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2024
0M
2025
Income statement
SEK thousands
Item
2024
2025
Revenue
529
730
Staff expenses
−63
−14
EBITDA
226
95
Depreciation & amort.
—
−2
EBIT
226
94
Net financials
0
1
Profit before tax
170
69
Tax
−35
−16
Net profit
135
54
Balance sheet
SEK thousands
Item
2024
2025
Total assets
361
659
Equity
185
239
Long-term debt
—
—
Short-term debt
120
339
Total debt
120
339
Financial ratios
5-year trend
EBITDA-margin
13.1%
This company
15.8%
Market median
-17% vs market
2024
2025
Soliditetsgrad
36.2%
This company
38.2%
Market median
+5% vs market
2024
2025
Egenkapitalforrentning
22.4%
This company
18.4%
Market median
+22% vs market
2024
2025
Nettoresultatgrad
7.3%
This company
8.1%
Market median
-10% vs market
2024
2025
Aktivomsætning
1.11×
This company
1.12×
Market median
+1% vs market
2024
2025
Gæld/egenkapital
1.76×
This company
0.62×
Market median
-184% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-03-14 – 2024-12-31
View
PDF
More on QSX AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
